ClinicalTrials.gg
Drug

Itacitinib clinical trials

Also written INCB039110.

studies test it
45
open now
2
in phase 3
2
first study started
2012

How each study uses itacitinib is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the itacitinib studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Itacitinib
41

Development codes

INCB039110
32
INCB389110
1
IBI377
1

Studies by the year they started

45 studies that test it; most in 2020 (8)

Studies that test itacitinib, by start year
YearStudies
20123
20132
20142
20151
20163
20171
20187
20197
20208
20214
20223
20234

Who runs them

Industry 23 · Other 22

Incyte Corporation (22) · M.D. Anderson Cancer Center (4) · University of Pennsylvania (2) · Assistance Publique - Hôpitaux de Paris (2) · Washington University School of Medicine (2) · City of Hope Medical Center (1) · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (1) · Fondazione per la Medicina Personalizzata (1)

Often tested with

Tested in the same studies.

Parsaclisib (2) · Cyclophosphamide (1) · Tacrolimus (1) · Tepotinib (1) · Dezapelisib (1) · Chimeric Antigen Receptor T-Cell Therapy|Chimeric Antigen Receptor T-cell Therapy (1) · Chimeric Antigen Receptor T-cells (1) · Adrenal Cortex Hormones (1)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 4

Studies that test itacitinib.

Studies

Open first, then newest update. How each study uses itacitinib is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 45

See all 45 studies that test itacitinib →

Given beside what is tested · 6 — itacitinib is usual care or a partner of the new treatment

Codes

What other systems call itacitinib · ClinicalTrials.gg INT001651

  • MeSH (NLM) C000718170itacitinibConfirmed ClinicalTrials.gov, NLM
  • UNII (FDA) 19J3781LPMITACITINIBConfirmed FDA, NLM, Wikidata
  • Wikidata Q27891174itacitinibConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C116855ItacitinibOne source FDA
  • DrugBank DB12154One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.